Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-038003
Filing Date
2019-06-27
Accepted
2019-06-27 20:00:59
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7147
  Complete submission text file 0001104659-19-038003.txt   8644
Mailing Address 440 SOUTH BROAD STREET, UNIT 1906 PHILADELPHIA PA 19146
Business Address
Rawcliffe Adrian (Reporting) CIK: 0001555851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 19926976

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)